IL4 and colitis: IL-4 modulation by iTcES in colitis and the recently described benefits of IL-4-stimulated (M2) macrophage transfer in colitis and colitis-associated colon cancer (CAC) highlight the therapeutic potential of M2 macrophages (Callejas et al. 2021).